Murano Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murano Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murano Trial Today - Breaking & Trending Today

Venetoclax and Rituximab Combination Maintains Survival Benefit in Relapsed/Refractory CLL

Published: October 9, 2023

Patients with relapsed/refractory chronic lymphocytic leukemia achieved sustained progression-free survival and overall survival benefit after treatment with fixed-duration venetoclax plus rituximab vs bendamustine plus rituximab, according to data from the phase 3 MURANO trial.

Source: onclive.com

Related Topics:

United StatesInternational WorkshopVenetoclax Plus RituximabChronic Lymphocytic LeukemiaMurano TrialInternational Workshop On CllJohnf SeymourPeter Maccallum Cancer CentreRoyal Melbourne Hospital